Inventor · disambiguated record
David Matthew Marquis
Also filed as: MARQUIS DAVID · MARQUIS DAVID M · MARQUIS DAVID MATTHEW
35 granted patents·8 pending applications·913 citations·filing 1976–2021
98Inventor score
Top patents by PatentIndex Score
43 records- 0198US8226611B2Anti-IL-6 antibodies, compositions, methods and usesCHEN YAN·Filed 2011·Granted Jul 24, 2012·64 cites·8 claims
- 0298US7560112B2Anti-il-6 antibodies, compositions, methods and usesAPPLIED MOLECULAR EVOLUTION·Filed 2006·Granted Jul 14, 2009·84 cites·16 claims
- 0398US4132670AMethod of preparing vanadium (IV) phosphate composition with high intrinsic surface areaCHEVRON RES·Filed 1976·Granted Jan 2, 1979·70 cites·6 claims
- 0497US8623362B2Anti-IL-6 antibodiesCHEN YAN·Filed 2012·Granted Jan 7, 2014·44 cites·11 claims
- 0597US8067003B2Methods of treating conditions using anti-IL-6 antibodiesCHEN YAN·Filed 2010·Granted Nov 29, 2011·46 cites·12 claims
- 0697US7833755B2Anti-IL-6 antibody nucleic acid molecules and methodsCHEN YAN·Filed 2009·Granted Nov 16, 2010·50 cites·12 claims
- 0797US7744874B2Anti-sclerostin antibodiesLILLY CO ELI·Filed 2008·Granted Jun 29, 2010·55 cites·10 claims
- 0895US7619069B2Antibodies to TGF-beta 1LILLY CO ELI·Filed 2007·Granted Nov 17, 2009·34 cites·13 claims
- 0994USRE43672EAnti-IL-6 antibodies, compositions, methods and usesCHAN YAN·Filed 2011·Granted Sep 18, 2012·47 cites·16 claims
- 1094US7872102B2Anti-IL-23 antibodiesLILLY CO ELI·Filed 2006·Granted Jan 18, 2011·36 cites·3 claims
- 1189US6207160B1aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologiesJOLLA PHARMA·Filed 1996·Granted Mar 27, 2001·70 cites·25 claims
- 1289US4231943AMaleic anhydride productionCHEVRON RES·Filed 1979·Granted Nov 4, 1980·27 cites·5 claims
- 1387US4187235AMethod for preparing maleic anhydrideCHEVRON RES·Filed 1978·Granted Feb 5, 1980·37 cites·3 claims
- 1485US5363915AEnhanced oil recovery technique employing nonionic surfactantsCHEVRON RES & TECH·Filed 1990·Granted Nov 15, 1994·51 cites·28 claims
- 1583US5874409AAPL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologiesJOLLA PHARMA·Filed 1995·Granted Feb 23, 1999·42 cites·2 claims
- 1681US12065488B2Anti-IL-6 antibodyJANSSEN BIOTECH INC·Filed 2021·Granted Aug 20, 2024·0 cites·4 claims
- 1781US7479271B2Humanized anti-ghrelin antibodiesLILLY CO ELI·Filed 2006·Granted Jan 20, 2009·4 cites·12 claims
- 1880US7101978B2TNF-α binding moleculesAPPLIED MOLECULAR EVOLUTION·Filed 2003·Granted Sep 5, 2006·9 cites·5 claims
- 1980US4071540AAnhydride separation processCHEVRON RES·Filed 1976·Granted Jan 31, 1978·12 cites·13 claims
- 2078US8153125B2CD20 binding moleculesWATKINS JEFFRY D·Filed 2004·Granted Apr 10, 2012·20 cites·11 claims
- 2178US7892546B2Anti-CXCR4 antibodiesLILLY CO ELI·Filed 2009·Granted Feb 22, 2011·2 cites·10 claims
- 2276US7901679B2Humanized anti-ghrelin antibodiesLILLY CO ELI·Filed 2007·Granted Mar 8, 2011·4 cites·4 claims
- 2375US7988970B2Methods of treatment comprising administering an anti-sclerostin antibodyLILLY CO ELI·Filed 2010·Granted Aug 2, 2011·2 cites·2 claims
- 2474US11180549B2Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibodyJANSSEN BIOTECH INC·Filed 2019·Granted Nov 23, 2021·0 cites·12 claims
- 2574US6858210B1Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using sameJOLLA PHARMA·Filed 1999·Granted Feb 22, 2005·33 cites·104 claims
- 2673US6410775B1APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologiesJOLLA PHARMA·Filed 1998·Granted Jun 25, 2002·18 cites·5 claims
- 2770US7435799B2TNF-α binding moleculesAPPLIED MOLECULAR EVOLUTION·Filed 2004·Granted Oct 14, 2008·1 cites·2 claims
- 2867US9340613B2Anti-IL-6 antibodies, compositions, methods and usesJANSSEN BIOTECH INC·Filed 2013·Granted May 17, 2016·0 cites·9 claims
- 2967US5076357AMethod of enhancing recovery of petroleum from an oil-bearing formationCHEVRON RES & TECH·Filed 1990·Granted Dec 31, 1991·43 cites·52 claims
- 3066US2004162413A1Methods of optimizing antibody variable region binding affinityFiled 2003·Application pending·0 cites
- 3165US8128927B2Methods of using TGF-β 1 binding compositionsDAVIES JULIAN·Filed 2009·Granted Mar 6, 2012·0 cites·8 claims
- 3265US2017253651A1Methods of Suppressing Rheumatoid Arthritis Using An Anti-IL-6 AntibodyJANSSEN BIOTECH INC·Filed 2017·Application pending·0 cites
- 3364US9631016B2Pen-injector device containing anti-IL-6 antibodiesJANSSEN BIOTECH INC·Filed 2016·Granted Apr 25, 2017·0 cites·13 claims
- 3463US4259246AMaleic anhydride production with recycle treatmentCHEVRON RES·Filed 1979·Granted Mar 31, 1981·6 cites·4 claims
- 3557US8003102B2Anti-CXCR4 antibodiesLILLY CO ELI·Filed 2010·Granted Aug 23, 2011·0 cites·2 claims
- 3655US2004009904A1APL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologiesFiled 2002·Application pending·0 cites
- 3751US2004131613A1TNF-alpha binding moleculesFiled 2003·Application pending·0 cites
- 3850US8257704B2Anti-sclerostin antibodiesKORYTKO ANDREW IHOR·Filed 2011·Granted Sep 4, 2012·0 cites·2 claims
- 3949US2005004351A1Therapeutic and diagnostic domain 1 beta2GP1 polypeptides and methods of using sameFiled 2004·Application pending·0 cites
- 4049US2009202986A1Methods of optimizing antibody variable region binding affinityHUSE WILLIAM D·Filed 2004·Application pending·0 cites
- 4148US2005208480A1aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologiesVICTORIA EDWARD J·Filed 2004·Application pending·0 cites
- 4242US2008089892A1Fc Region VariantsLILLY CO ELI·Filed 2005·Application pending·0 cites
- 4340US4340758ANitration process for the preparation of 2,6-dialkylanilineCHEVRON RES·Filed 1981·Granted Jul 20, 1982·2 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when David Matthew Marquis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →